4Chibber R, et al. Toxic action of advanced giycation end prodacts on cultured retinal capillary pericytos and endothelial cells relevance to diabetic retinopathy [J]. Diabetologyia , 1997 ,40:156.
5Murata T , et al. The realationship between accumuiation of advanced giycation end prodactsand expression of vascular endothelial growth factor in human diabetic retinas [J]. Diabetologyia , 1997 ,40:764- 769.
6Bierhaus A, et al. Cyclosporina inhibits monocyte tissue factor activation in cardiac transplat recipients[J]. Circulation , 1997 ,96(7) :2262.
7Limb GA, et al. Distribution of TNF alpha and its reactive vasaular adhesion moleenles in fibrovaseular membranes of proliforative diabetic retinopathy[J]. Br J Ophthalmol, 1996 ,80(2):168.
8Kvanta. Expression and secretion of transfomling growth factor - beta in transformedand nontransformed retinal pigment epithelial cells[J]. Ophthalmic Res, 1994, 26(6):361.
9Spranger J, et al. Deffient antivatipon and different expression of transfomling growth factor - bctais forms inactive proliforative diabetic retinopathy and neovascular eye diease[J]. Exp Clin Endocrinol diabetes, 1999, 107( 1 ) :21.
10Miller JW ,et al. Degression of experimental iris neovascularization with systemic alpha- interferom[J]. Ophthalnmlogy ,1993, 100:9.
